Initial and discharged treatment regimens for cancer patients with IPE (n = 904)
| Treatment . | No. of patients (%) . |
|---|---|
| Initial treatment | |
| LMWH | 761 (84.2) |
| Enoxaparin | 578 (63.9) |
| Dalteparin | 183 (20.2) |
| Unfractionated heparin | 63 (7.0) |
| Direct oral anticoagulant | 6 (0.7) |
| Factor Xa inhibitor | 5 (0.6) |
| Direct thrombin inhibitor | 1 (0.1) |
| No initial treatment | 68 (7.5) |
| Discharged treatment | |
| LMWH | 796 (88.1) |
| Enoxaparin | 604 (66.8) |
| Dalteparin | 192 (21.2) |
| Direct oral anticoagulant | 14 (1.5) |
| Factor Xa inhibitor | 8 (0.9) |
| Warfarin | 6 (0.7) |
| Direct thrombin inhibitor | 1 (0.1) |
| No discharged treatment | 79 (8.7) |
| No medications or IVC filter | 27 (3.0) |
| IVC filter placement only | 52 (5.8) |
| In-hospital IVC filter placement | |
| No | 823 (91.0) |
| Yes | 81 (9.0) |
| Treatment . | No. of patients (%) . |
|---|---|
| Initial treatment | |
| LMWH | 761 (84.2) |
| Enoxaparin | 578 (63.9) |
| Dalteparin | 183 (20.2) |
| Unfractionated heparin | 63 (7.0) |
| Direct oral anticoagulant | 6 (0.7) |
| Factor Xa inhibitor | 5 (0.6) |
| Direct thrombin inhibitor | 1 (0.1) |
| No initial treatment | 68 (7.5) |
| Discharged treatment | |
| LMWH | 796 (88.1) |
| Enoxaparin | 604 (66.8) |
| Dalteparin | 192 (21.2) |
| Direct oral anticoagulant | 14 (1.5) |
| Factor Xa inhibitor | 8 (0.9) |
| Warfarin | 6 (0.7) |
| Direct thrombin inhibitor | 1 (0.1) |
| No discharged treatment | 79 (8.7) |
| No medications or IVC filter | 27 (3.0) |
| IVC filter placement only | 52 (5.8) |
| In-hospital IVC filter placement | |
| No | 823 (91.0) |
| Yes | 81 (9.0) |